Skip to content
Lower risk Drug recall · FDA · Published July 17, 2019

Lupin Nystatin Cream Recall: Failed Content Uniformity Risk

Lupin Pharmaceuticals recalls Nystatin and Triamcinolone Acetonide Cream due to failed content uniformity tests at 9 months. This may affect product stability and safety for patients using prescription medication.

🇺🇸 FDA recall #D-1518-2019DrugLupin ›
Take action

Contact the company

Recalling firmLupin Pharmaceuticals Inc.111 S Calvert St Fl 21ST · Baltimore, MD 21202-6174
✎ GovInfoNow plain-language explainer

Lupin Pharmaceuticals is recalling a specific prescription cream product because testing showed inconsistent drug content over time. This could mean the medication isn't working properly for patients who need it. Read more at govinfonow.com/recall/38272-lupin-nystatin-cream-recall-failed-content-uniformity-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/38272-lupin-nystatin-cream-recall-failed-content-uniformity-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-1518-2019

Cite this page

“Lupin Nystatin Cream Recall: Failed Content Uniformity Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38272-lupin-nystatin-cream-recall-failed-content-uniformity-risk. Based on FDA recall #D-1518-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1518-2019%22&limit=1).

The FDA announced on July 17, 2019, that Lupin Pharmaceuticals Inc. voluntarily recalled Nystatin and Triamcinolone Acetonide Cream USP due to failed content uniformity specifications. The recall affects 33,939 tubes distributed nationwide.

How to tell if you have it

  • Brand: Lupin
  • Product: Nystatin and Triamcinolone Acetonide Cream USP100,000 units/g, 0.1%, 15 g tube, Rx only
  • NDC: 68180-545-01
  • Lot #: K800245 (Exp. Dec 2019), K900036 (Exp. Sep 20), K900153 (Exp. 09/2020)

The hazard

The product failed content uniformity specifications, with an out-of-specification result observed in the uniformity of containers test at the 9-month long-term stability condition for upright orientation.

Context

GovInfoNow's records show Lupin Pharmaceuticals Inc. has 90 other recalls on record since January 31, 2013. Other recent recalls by the brand include a Clobetasol Cream recall on August 3, 2026, and a Glucagon Emergency Kit recall on June 23, 2026. Other recent recalls of similar products include a Sun Pharmaceutical Fluocinonide Cream Recall on March 25, 2026, and a Padagis Nystatin Cream Recall on June 23, 2026.

How to tell if you have this one

Check for the product name 'Nystatin and Triamcinolone Acetonide Cream USP' with 15g tube size. It was manufactured by Lupin with specific lot numbers and expiration dates listed in the recall notice.

  • Brand
    Lupin
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the product name, 15g tube size, and lot numbers (K800245, K900036, K900153) on the packaging.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 14 months after the firm started it.

1. Firm started the recall: Jul 17, 201912. FDA classified it Class III: Jul 25, 201923. Published in FDA’s Enforcement Report: Jul 31, 201934. FDA terminated the recall: Sep 14, 2020420192020
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Lupin recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1518-2019 (July 17, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1518-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA